Hospital monopolies in the U.S. are driving up the cost of knee replacement surgery compared to competitive markets [1].
This trend highlights how the consolidation of healthcare providers can directly impact patient expenses and the overall affordability of medical care. When competition disappears, dominant hospital systems gain the power to set higher prices for essential procedures.
Data released following the implementation of a 2021 federal hospital price-transparency rule reveals a stark divide in pricing [1]. In markets characterized by monopolies, the cost of knee replacement surgery is roughly twice as high as in markets where multiple providers compete [1].
Asheville, North Carolina, serves as a primary example of this phenomenon [1]. In this region, hospital mergers have reduced the number of available providers, allowing the remaining dominant systems to increase charges for services [1].
Healthcare analysts said that mergers reduce the incentive for hospitals to lower prices to attract patients [3]. In a competitive landscape, facilities often vie for patients by offering more efficient pricing or better value. However, in monopoly markets, patients have fewer alternatives, which removes the pressure on hospitals to remain cost-competitive [3].
The transparency rule was designed to provide patients and insurers with a clearer understanding of what they are paying for medical services. By making this data public, the disparity in pricing between consolidated and competitive markets has become more apparent [1].
These findings suggest that the financial burden on patients is not solely a result of the complexity of the surgery or the cost of materials; it is often a result of market structure [3].
“Knee replacement surgery costs are roughly twice as high in monopoly markets compared with competitive markets”
The correlation between hospital consolidation and increased pricing suggests that federal antitrust oversight may be critical in controlling healthcare inflation. As hospital systems continue to merge, the lack of competition transforms medical services into a captured market, where the price is determined by corporate leverage rather than the actual cost of care.
